Volume : XI, Issue : VII, July - 2021
A RANDOMIZED CONTROLLED TRIAL OF LOW DOSE ANTI-THYMOCYTE GLOBULIN PLUS RITUXIMAB VERSUS CONVENTIONAL DOSE OF ANTI -THYMOCYTE GLOBULIN ALONE AS INDUCTION AGENT IN HIGH-RISK RENAL TRANSPLANT RECIPIENTS.
Dr. Srilatha Vadlamudi, Dr. Sireesha Gunnam, Dr. Moturu Venkata Viswanath
Abstract :
Keywords :
Article:
Download PDF
DOI : 10.36106/ijar
Cite This Article:
A RANDOMIZED CONTROLLED TRIAL OF LOW DOSE ANTI-THYMOCYTE GLOBULIN PLUS RITUXIMAB VERSUS CONVENTIONAL DOSE OF ANTI -THYMOCYTE GLOBULIN ALONE AS INDUCTION AGENT IN HIGH-RISK RENAL TRANSPLANT RECIPIENTS., Dr. Srilatha Vadlamudi, Dr. Sireesha Gunnam, Dr. Moturu Venkata Viswanath INDIAN JOURNAL OF APPLIED RESEARCH : Volume-11 | Issue-7 | July-2021
Number of Downloads : 140
A RANDOMIZED CONTROLLED TRIAL OF LOW DOSE ANTI-THYMOCYTE GLOBULIN PLUS RITUXIMAB VERSUS CONVENTIONAL DOSE OF ANTI -THYMOCYTE GLOBULIN ALONE AS INDUCTION AGENT IN HIGH-RISK RENAL TRANSPLANT RECIPIENTS., Dr. Srilatha Vadlamudi, Dr. Sireesha Gunnam, Dr. Moturu Venkata Viswanath INDIAN JOURNAL OF APPLIED RESEARCH : Volume-11 | Issue-7 | July-2021
Our Other Journals...
-
International Journal of
Scientific Research Visit Website -
PARIPEX Indian Journal
of Research Visit Website -
Global Journal for
Research Analysis Visit Website